[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-04-28-1":3},{"date":4,"filings":5,"has_more":610,"limit":611,"page":612,"total_count":613},"2026-04-28",[6,14,21,29,35,40,45,50,57,64,69,75,82,89,95,102,109,114,120,127,133,139,146,153,158,165,172,179,184,190,197,204,209,215,221,228,234,241,248,254,259,266,273,277,283,290,296,303,308,312,318,325,332,339,346,353,358,363,369,375,381,388,395,400,406,411,416,421,426,431,436,441,448,455,460,465,470,477,482,487,492,499,506,511,518,524,529,534,540,547,552,557,564,569,574,581,588,593,598,603],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"Star Health and Allied Insurance Company Limited","2026-04-28T23:56:38.883000","NSE","Star Health FY26: Core Business Shines, Q4 Net Loss Due to Investment Volatility","69f0fc1c0c6b4fb98a91e537","STARHEALTH","*   **FY26 Performance:** Gross Written Premium (GWP) grew 16% to ₹20,369 Cr. The company achieved a significant turnaround with an underwriting profit of ₹206 Cr, compared to a loss last year.\n*   **Q4 Net Loss:** Despite strong operations, the company reported a net loss of ₹(55) Cr for Q4 FY26, a sharp reversal from a ₹271 Cr profit in the same quarter last year.\n*   **Investment Impact:** The quarterly loss was driven entirely by a massive Mark-to-Market (MTM) investment loss of ₹(558) Cr, which wiped out underwriting profits.\n*   **Strong Core Business:** The combined ratio improved to a profitable 98.8% for the full year. Normalised PAT (adjusting for investment volatility) grew by a strong 45% to ₹1,222 Cr, showing robust underlying operational health.\n*   **Retail Growth:** The core retail segment showed excellent momentum, with Retail Fresh GWP growing by 37% year-over-year.",{"company_name":15,"filing_date":16,"filing_source":9,"headline":17,"id":18,"stock_code":19,"summary_text":20},"Diensten Tech Limited","2026-04-28T23:51:39.470000","Share Capital Audit Confirms No Changes for Q4 FY26","69f0fae0ec7f5de862c54293","DTL","*   Submitted the Reconciliation of Share Capital Audit Report and RTA certificate for the quarter ended March 31, 2026.\n*   The audit confirmed there were no changes to the company's share capital during the quarter.\n*   Shareholding is nearly 100% dematerialized, with only 4 shares remaining in physical form.\n*   The compliance report was clean, with no discrepancies or delays in shareholder services noted.\n*   The company is listed on the NSE Emerge (SME) platform, which is a key consideration for investors.",{"company_name":22,"filing_date":23,"filing_source":24,"headline":25,"id":26,"stock_code":27,"summary_text":28},"KSB Ltd","2026-04-28T23:36:41.088000","BSE","KSB Ltd's 2025 BRSR: Hits GHG Targets, Reveals High Worker Turnover","69f0f77fa157653c6639ca78","KSB","*   Achieved a 59% reduction in Scope 1 & 2 GHG emissions, far exceeding its 30% target for 2025.\n*   Renewable energy now accounts for 65% of total electricity consumption, driven by solar capacity and PPAs.\n*   Reported zero regulatory penalties, corruption cases, or investor grievances for FY 2025, indicating strong governance.\n*   Revealed an extremely high turnover rate of 76.6% for permanent workers, a significant red flag.\n*   Reported a 0% retention rate for permanent female employees returning from parental leave, raising concerns about retaining female talent.",{"company_name":30,"filing_date":31,"filing_source":9,"headline":32,"id":33,"stock_code":27,"summary_text":34},"Ksb Limited","2026-04-28T23:36:39.592000","FY25 BRSR: Exceeds Green Targets, But Faces High Turnover & Rising Related Party Sales","69f0f780abd16353d2ff6815","*   ✅ \u003Cb>Strong Green Performance:\u003C\u002Fb> Significantly exceeded 2025 targets for GHG emission reduction (59% achieved vs 30% goal) and renewable energy share (65% vs 40% goal).\n*   ☀️ \u003Cb>Solar Pump Growth:\u003C\u002Fb> Sales of solar pumps contributed 9.18% to total revenue in FY25, showing diversification into sustainable products.\n*   🚩 \u003Cb>High Employee Turnover:\u003C\u002Fb> Reported extremely high turnover rates for permanent employees (29.50%) and permanent workers (76.60%), a major red flag.\n*   🚩 \u003Cb>Increased Related Party Sales:\u003C\u002Fb> Sales to related parties rose notably to 12.50% of total sales, up from 9.33% in the prior year.\n*   ⚠️ \u003Cb>Other Concerns:\u003C\u002Fb> The company missed its female employee hiring target and recorded over 25,000 customer complaints (though all were resolved).",{"company_name":30,"filing_date":36,"filing_source":9,"headline":37,"id":38,"stock_code":27,"summary_text":39},"2026-04-28T23:36:39.532000","AGM on May 20: Dividend & MD Reappointment on the Agenda","69f0f74af43b112c8d91dfee","*   The 66th Annual General Meeting (AGM) is scheduled for **May 20, 2026**, to be held via video conference.\n*   Shareholders will vote on a resolution to declare a **dividend** for the financial year 2025.\n*   A **special resolution** is proposed for the reappointment of the Managing Director and the approval of their remuneration, a key item requiring a 75% majority.\n*   The agenda also includes the re-appointment of Mr. Gaurav Swarup as a Director and the adoption of the financial statements for the year ended Dec 31, 2025.",{"company_name":22,"filing_date":41,"filing_source":24,"headline":42,"id":43,"stock_code":27,"summary_text":44},"2026-04-28T23:31:40.402000","FY25 Report: Strong Growth & Dividend, but Auditor Flags Major Governance Issues","69f0f698ec7f5de862c54283","*   **Financials (FY25):** Revenue grew 6.4% to ₹26,957.28 million, with Total Segment Profit up to ₹3,544.31 million. The Valves segment was the fastest growing at 13.11%.\n*   **Dividend:** The Board has proposed a final dividend of ₹4.40 per equity share (220%) for the financial year.\n*   **Operational Strength:** Exports reached a new high, contributing 17% of total order intake. The company enters FY26 with a healthy order book, citing strong demand from energy and water sectors.\n*   **Management Continuity:** The Board approved the re-appointment of Mr. Rajeev Jain as Managing Director for a period of five years, subject to shareholder approval.\n*   🔴 **AUDITOR RED FLAGS:** The Independent Auditor's Report contains significant qualifications on internal financial controls. It notes that the \"audit trail (edit log) is not maintained for certain information\" and other features were not enabled, a major compliance and governance concern.\n*   🔴 **Working Capital Stress:** Debtors Turnover days increased significantly from 83 to 103 days, and Inventory Turnover days rose from 165 to 179 days, indicating potential stress on collections and inventory management.\n*   **Exceptional Item:** An exceptional charge of ₹255.48 million was booked due to the incremental impact of new labour codes on gratuity liability.",{"company_name":30,"filing_date":46,"filing_source":9,"headline":47,"id":48,"stock_code":27,"summary_text":49},"2026-04-28T23:26:39.087000","FY25 Annual Report: Strong Growth, 220% Dividend, and a Key Auditor Finding","69f0f569890e096a6fc54727","*   \u003Cb>FY25 Performance:\u003C\u002Fb> Revenue from operations grew 6.42% YoY to ₹26,957.28 million, with total segment profit margin expanding to 13.15% from 11.69%.\n*   \u003Cb>Dividend Declared:\u003C\u002Fb> The Board proposed a final dividend of 220% (₹4.40 per share) for the financial year ended 31st December, 2025.\n*   \u003Cb>Strong Order Book:\u003C\u002Fb> Recorded a healthy order intake of ₹29,920 million, with the Valves segment showing the highest revenue growth at 13.11%.\n*   \u003Cb>Leadership Continuity:\u003C\u002Fb> The Board has recommended the re-appointment of Mr. Rajeev Jain as Managing Director for a 5-year term, a key resolution for the upcoming AGM.\n*   \u003Cb>Auditor's Red Flag:\u003C\u002Fb> The auditor's report highlighted a material compliance weakness, noting that the backup of the company's audit trail (edit log) was not maintained on servers physically located in India.",{"company_name":51,"filing_date":52,"filing_source":9,"headline":53,"id":54,"stock_code":55,"summary_text":56},"JB Chemicals & Pharmaceuticals Limited","2026-04-28T23:26:38.923000","Shareholders Approve Amalgamation with Torrent Pharmaceuticals","69f0f50aa157653c6639ca6b","JBCHEPHARM","*   Shareholders have approved the Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Ltd. with Torrent Pharmaceuticals Ltd.\n*   The resolution was passed with overwhelming support (nearly 100% of valid votes in favour) at a National Company Law Tribunal (NCLT) convened meeting on April 28, 2026.\n*   This approval is a critical milestone in the merger process, which remains subject to the final sanction by the NCLT.",{"company_name":58,"filing_date":59,"filing_source":9,"headline":60,"id":61,"stock_code":62,"summary_text":63},"CESC Limited","2026-04-28T23:21:40.255000","Board Meeting on May 8 to Approve FY26 Financials","69f0f3d058d874434539c814","CESC","• The Board of Directors will meet on **08 May 2026**.\n• The primary agenda is to consider and approve the Audited Standalone and Consolidated Financial Results for the financial year ended 31 March 2026.\n• This filing is an advance intimation of the meeting; no financial or operational data is disclosed in this document.",{"company_name":22,"filing_date":65,"filing_source":24,"headline":66,"id":67,"stock_code":27,"summary_text":68},"2026-04-28T23:21:40.132000","FY25 Report: Strong Growth & Dividend, But Auditor Notes Key Compliance Issue","69f0f437f35e30561cff62f7","*   \u003Cb>Financials (FY25):\u003C\u002Fb> Consolidated Revenue grew 6.3% YoY to ₹26,796 Mn. Total Segment Profit surged 19.7% to ₹3,544 Mn.\n*   \u003Cb>Order Book:\u003C\u002Fb> Achieved a record order intake of ₹29,920 Mn, with exports hitting a new high and contributing 17% of the total.\n*   \u003Cb>Dividend:\u003C\u002Fb> The Board has proposed a final dividend of ₹4.40 per share (220% on a face value of ₹2).\n*   \u003Cb>Management:\u003C\u002Fb> The Board approved the re-appointment of Mr. Rajeev Jain as Managing Director for 5 years, subject to shareholder approval.\n*   \u003Cb>Auditor's Qualification:\u003C\u002Fb> The Independent Auditor's Report includes a qualification (a red flag) regarding non-compliance with rules for maintaining the audit trail (edit log) of its accounting software, flagging a significant governance weakness.",{"company_name":70,"filing_date":71,"filing_source":24,"headline":72,"id":73,"stock_code":55,"summary_text":74},"JB Chemicals & Pharmaceuticals Ltd","2026-04-28T23:21:40.046000","Shareholders Approve Merger with Torrent Pharmaceuticals","69f0f3e35236ec998939c587","• Shareholders have approved the Scheme of Amalgamation for the company to merge with Torrent Pharmaceuticals Limited.\n• The resolution was passed with an overwhelming majority at an NCLT-convened meeting, with 100% of the value of valid votes cast in favour.\n• This is a transformative event for the company, and upon completion, shareholders of J.B. Chemicals will receive consideration as per the terms of the amalgamation.\n• The meeting was held on April 28, 2026, as directed by the National Company Law Tribunal (NCLT) to vote on the merger.",{"company_name":76,"filing_date":77,"filing_source":9,"headline":78,"id":79,"stock_code":80,"summary_text":81},"Transindia Real Estate Limited","2026-04-28T23:16:39.292000","Acquires Land in Kolkata via ₹ 84 Crore Deal","69f0f2b3ec7f5de862c54275","TREL","*   Acquiring 100% of three companies for a total of **₹ 84 Crores** in cash.\n*   The deal is to secure a land parcel in the strategic logistics hub of **Dankuni, Kolkata**.\n*   One company, Panchghara Landscape Pvt. Ltd., has officially become a wholly-owned subsidiary.\n*   **Key Risk:** The company was unable to aggregate the entire land parcel, securing only **~86% of the planned ~44 acres**, which may impact the project's scale and returns.",{"company_name":83,"filing_date":84,"filing_source":9,"headline":85,"id":86,"stock_code":87,"summary_text":88},"InfoBeans Technologies Limited","2026-04-28T23:16:39.188000","FY26 Profit Jumps 128%, Rewards Shareholders with 4x Dividend","69f0f2acf35e30561cff62f4","INFOBEAN","*   📈 **Stellar FY26 Performance:** Profit After Tax (PAT) surged 128% YoY to ₹87 Cr, while revenue grew 32% to ₹539 Cr.\n*   💰 **Quadrupled Dividend:** The company announced a total dividend of ₹1.00 per share for FY26 (a 4x increase), including a special dividend of ₹0.50 due to excellent growth.\n*   🤖 **AI Strategy Success:** AI-augmented software development now accounts for 43% of the company's revenue, highlighting a successful strategic pivot.\n*   🏆 **Record Quarter:** Q4 FY26 was declared the \"best quarter in company history,\" with revenue hitting ₹147 Cr and PAT growing 104% YoY.",{"company_name":90,"filing_date":91,"filing_source":24,"headline":92,"id":93,"stock_code":87,"summary_text":94},"Infobeans Technologies Ltd","2026-04-28T23:11:40.452000","FY26 Profit Soars 128%, Dividend Quadrupled","69f0f18e890e096a6fc54712","• \u003Cb>Record Annual Profit:\u003C\u002Fb> Full-year Profit After Tax (PAT) surged by 128% YoY to ₹87 crore from ₹38 crore.\n• \u003Cb>Massive Dividend Hike:\u003C\u002Fb> The Board declared a total dividend of ₹1.00 per share for FY26, a 400% (4x) increase from the previous year's ₹0.25 per share.\n• \u003Cb>Strong Revenue Growth:\u003C\u002Fb> Annual revenue grew by 32% YoY, reaching ₹539 crore, while Q4 revenue grew 37% YoY.\n• \u003Cb>AI Strategy Pays Off:\u003C\u002Fb> 43% of the company's annual revenue was generated from AI-augmented software development, highlighting successful strategic execution.\n• \u003Cb>Best Quarter Ever:\u003C\u002Fb> Q4 FY26 was the best in company history, with PAT growing 104% YoY to ₹21 crore.",{"company_name":96,"filing_date":97,"filing_source":24,"headline":98,"id":99,"stock_code":100,"summary_text":101},"Quality Power Electrical Equipments Ltd","2026-04-28T23:11:40.432000","FY26 Compliance Update: Not a Large Corporate & Nil Borrowings","69f0f17c5236ec998939c57d","QPOWER","*   The company has confirmed it is **not a Large Corporate** as of March 31, 2026, based on SEBI criteria.\n*   It reported **\"Nil\" incremental borrowings** for the financial year 2025-2026.\n*   Consequently, the company is **exempt from the mandatory requirement** to raise 25% of its incremental borrowings through debt securities.\n*   This disclosure was filed with the stock exchanges for the financial year ending March 31, 2026.",{"company_name":103,"filing_date":104,"filing_source":9,"headline":105,"id":106,"stock_code":107,"summary_text":108},"Indian Terrain Fashions Limited","2026-04-28T23:11:39.434000","Shareholder Vote on All Independent Directors","69f0f17aa157653c6639ca59","INDTERRAIN","*   The company has initiated a Postal Ballot to seek shareholder approval regarding the \"candidature of all the Independent Directors.\"\n*   Voting will be conducted exclusively through a remote e-voting platform.\n*   **Voting Period**: Starts at 9:00 AM on April 29, 2026, and ends at 5:00 PM on May 28, 2026.\n*   **Eligibility**: Shareholders on record as of the cut-off date, April 24, 2026, are eligible to vote.",{"company_name":58,"filing_date":110,"filing_source":9,"headline":111,"id":112,"stock_code":62,"summary_text":113},"2026-04-28T23:11:39.270000","Board Meeting Scheduled to Approve Annual Financials","69f0f178f43b112c8d91dfd9","*   A Board of Directors meeting is scheduled for **May 06, 2026**.\n*   The key agenda is to approve the audited annual financial results (standalone & consolidated) for the year ended March 31, 2026.\n*   A potential dividend recommendation for the financial year may also be considered at this meeting.\n*   This is a critical event for investors, with the results providing a comprehensive view of the company's performance for FY 2025-26.",{"company_name":115,"filing_date":116,"filing_source":24,"headline":117,"id":118,"stock_code":107,"summary_text":119},"Indian Terrain Fashions Ltd","2026-04-28T23:06:41.413000","Shareholder Vote on Independent Directors","69f0f0545236ec998939c576","*   The company has initiated a postal ballot for shareholders to vote on the appointment\u002Fre-appointment of all its Independent Directors.\n*   Voting will be conducted exclusively through a remote e-voting process.\n*   The e-voting period is from Wednesday, April 29, 2026, to Thursday, May 28, 2026.\n*   Results of the vote will be declared by Saturday, May 30, 2026.",{"company_name":121,"filing_date":122,"filing_source":24,"headline":123,"id":124,"stock_code":125,"summary_text":126},"KPIT Technologies Ltd","2026-04-28T23:06:41.323000","Approves Grant of 21,000 Stock Options to Employees","69f0f04df35e30561cff62ec","KRBL","*   The Nomination and Remuneration Committee has approved the grant of 21,000 stock options to eligible employees under its RSU Plan 2022.\n*   Each option allows the holder to acquire one equity share of the company.\n*   The exercise price is set at the face value of the share, which is ₹10 per option.\n*   Options will vest over a period of 1 to 4 years from the grant date of April 28, 2026.\n*   This grant will lead to a potential equity dilution of up to 21,000 shares upon future exercise.",{"company_name":128,"filing_date":129,"filing_source":24,"headline":130,"id":131,"stock_code":80,"summary_text":132},"Transindia Real Estate Ltd","2026-04-28T23:06:41.295000","Announces ₹84 Crore Land Acquisition for Kolkata Logistics Hub","69f0f05f0c6b4fb98a91e4f8","*   The company is acquiring 100% of three companies for a total consideration of **approx. ₹84 Crore** in cash.\n*   This acquisition is for an underlying land asset in Dankuni, Kolkata, intended for logistics and warehousing development to enhance market presence.\n*   **Key Detail:** Due to \"constraints in land aggregation,\" the company has only acquired **~86% of the originally planned ~44-acre land parcel**, which is a material deviation and potential risk.\n*   One acquisition is complete, making Panchghara Landscape Private Limited a wholly-owned subsidiary. The other two are expected to be completed within 45 days.",{"company_name":134,"filing_date":135,"filing_source":24,"headline":136,"id":137,"stock_code":62,"summary_text":138},"CESC Ltd","2026-04-28T23:01:41.059000","Board Meeting Scheduled to Approve FY26 Financial Results","69f0ef2d890e096a6fc54704","*   A meeting of the Board of Directors is scheduled to be held on Wednesday, May 6, 2026.\n*   The primary agenda is to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended March 31, 2026.\n*   This filing is an advance notice as per SEBI regulations; it does not contain the financial results or disclose any other corporate actions.",{"company_name":140,"filing_date":141,"filing_source":24,"headline":142,"id":143,"stock_code":144,"summary_text":145},"LGB Forge Ltd","2026-04-28T23:01:41.037000","Confirms It Is Not a 'Large Corporate' for FY26","69f0ef28a157653c6639ca4b","533007","*   LGB Forge has formally declared that it does not meet the criteria to be classified as a \"Large Corporate\" for the financial year ended March 31, 2026.\n*   As a result, the company is not obligated to raise a mandatory portion of its borrowings through debt securities, giving it more financing flexibility.\n*   This filing is a routine compliance declaration made to the stock exchange and does not contain any new operational or financial performance data.\n*   The company has confirmed there are no red flags associated with this update; it is a standard procedural notice.",{"company_name":147,"filing_date":148,"filing_source":9,"headline":149,"id":150,"stock_code":151,"summary_text":152},"KPIT Technologies Limited","2026-04-28T23:01:39.400000","Grants 21,000 Stock Options to Employees","69f0ef1ff43b112c8d91dfd1","KPITTECH","*   The Nomination and Remuneration Committee has approved the grant of 21,000 stock options to eligible employees under the company's \"RSU Plan 2022\".\n*   The exercise price is set at the face value of ₹10 per share, which is significantly below the typical market price.\n*   Options will vest over a period of 1 to 4 years from the date of grant.\n*   The action will result in a potential equity dilution of up to 21,000 shares for existing shareholders upon exercise.",{"company_name":140,"filing_date":154,"filing_source":24,"headline":155,"id":156,"stock_code":144,"summary_text":157},"2026-04-28T22:56:40.321000","Confirms It Is Not a 'Large Corporate', Exempt from SEBI Mandate","69f0edf5ecaa861d9491e2a2","*   The company has declared it does not meet the criteria to be classified as a \"Large Corporate\" for the financial year ended March 31, 2026.\n*   As a result, it is exempt from the SEBI mandate requiring such companies to raise a portion of their incremental borrowings through debt securities.\n*   The filing confirms the company's long-term credit rating as 'Crisil BBB-' and outstanding borrowings of ₹22.15 Crores.",{"company_name":159,"filing_date":160,"filing_source":24,"headline":161,"id":162,"stock_code":163,"summary_text":164},"Sapphire Foods India Ltd","2026-04-28T22:56:40.265000","Earnings Call Audio for Q4 & FY26 Released","69f0edf7a157653c6639ca43","SAPPHIRE","• The audio recording of the Investors' Earnings Call for the quarter and year ended March 31, 2026 (Q4 FY26) is now available.\n• This filing is a procedural notice and does not contain any financial results or operational highlights.\n• Investors are directed to the audio recording on the company's website for details on performance and management commentary.",{"company_name":166,"filing_date":167,"filing_source":9,"headline":168,"id":169,"stock_code":170,"summary_text":171},"Torrent Pharmaceuticals Limited","2026-04-28T22:56:39.583000","Shareholders Approve Amalgamation with J. B. Chemicals & Pharmaceuticals","69f0ee0ff43b112c8d91dfce","TORNTPHARM","• Equity shareholders have approved the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited (“JB Pharma”) with Torrent Pharmaceuticals Limited.\n• The resolution was passed with an overwhelming majority, receiving 100% of the valid votes by value, far exceeding the required 75% threshold.\n• The meeting was convened on April 28, 2026, as directed by the National Company Law Tribunal (NCLT) to vote on the merger.\n• This approval is a critical step in a major strategic acquisition that is expected to significantly alter Torrent Pharma's scale, market position, and financial profile.",{"company_name":173,"filing_date":174,"filing_source":24,"headline":175,"id":176,"stock_code":177,"summary_text":178},"Chennai Petroleum Corporation Ltd","2026-04-28T22:51:41.596000","Stellar FY26 Results: Highest-Ever Dividend & Bonus Issue Hinted","69f0ece00c6b4fb98a91e4e3","CHENNPETRO","*   The Board recommended a final dividend of **₹54 per share**, resulting in a total dividend of **₹62 per share** for FY26 – the highest in the company's history.\n*   Management stated that a **bonus issue** will be considered by the Board at an \"appropriate time\" in light of the company's large reserves.\n*   Reported a \"stellar performance\" for FY26, achieving its **highest-ever crude throughput** (11.71 MMT) and a strong Q4 Gross Refining Margin (GRM) of **$13.75\u002Fbbl**.\n*   Key growth projects are underway, including a **₹1,600 crore Lube Oil Base Stock (LOBS) project** and entry into retail outlets.\n*   A key risk was highlighted: recent crude supply disruptions from the Middle East due to geopolitical tensions in the **Strait of Hormuz**.\n*   A planned maintenance shutdown is scheduled for a refinery unit around Sep-Oct 2026, which may impact future throughput.",{"company_name":96,"filing_date":180,"filing_source":24,"headline":181,"id":182,"stock_code":100,"summary_text":183},"2026-04-28T22:51:41.553000","Reports Zero Debt, Confirms 'Not a Large Corporate' Status","69f0ecc7a157653c6639ca3b","*   Declared it is **\"Not a Large Corporate\"** for the financial year beginning April 1, 2026, as per SEBI regulations.\n*   Reported **Nil (₹0 Crores) in outstanding borrowings** as of March 31, 2026, indicating a debt-free balance sheet.\n*   Due to this status, the company is not required to raise a specified portion of its incremental borrowings through debt securities.\n*   The filing was made in compliance with SEBI circulars regarding fund raising by large corporates.",{"company_name":185,"filing_date":186,"filing_source":9,"headline":187,"id":188,"stock_code":163,"summary_text":189},"Sapphire Foods India Limited","2026-04-28T22:51:39.605000","Q4 FY26 Earnings Call Recording Now Available","69f0ecc7ec7f5de862c5425e","\u003Cul>\n\u003Cli>The audio recording for the earnings call discussing financial results for the quarter and year ended March 31, 2026 (Q4 FY26) is now public.\u003C\u002Fli>\n\u003Cli>This filing is a routine compliance update under SEBI regulations to enhance transparency for investors.\u003C\u002Fli>\n\u003Cli>The recording can be accessed on the company's website, providing direct insight into management's discussion on performance and outlook.\u003C\u002Fli>\n\u003Cli>Please note: This filing provides the link to the audio and does not contain the financial results themselves.\u003C\u002Fli>\n\u003C\u002Ful>",{"company_name":191,"filing_date":192,"filing_source":9,"headline":193,"id":194,"stock_code":195,"summary_text":196},"Firstsource Solutions Limited","2026-04-28T22:46:38.923000","Top Legal Executive Steps Down","69f0eb900c6b4fb98a91e4dc","FSL","*   **Event:** Ms. Jagriti Bhattacharyya, the Executive Vice President - General Counsel, has resigned from her senior management position.\n*   **Effective Date:** Her last day with the company will be June 30, 2026.\n*   **Key Detail:** The resignation provides a two-month notice period for a smooth transition. The reason for her departure was not disclosed in the filing.",{"company_name":198,"filing_date":199,"filing_source":9,"headline":200,"id":201,"stock_code":202,"summary_text":203},"Concord Enviro Systems Limited","2026-04-28T22:46:38.904000","Shareholders Approve Scheme of Arrangement for Corporate Restructuring","69f0ebb4a157653c6639ca35","CEWATER","*   Equity Shareholders have approved the \"Scheme of Arrangement\" in a meeting convened by the National Company Law Tribunal (NCLT) on April 28, 2026.\n*   The special resolution passed with an overwhelming majority of 99.9972% of the votes cast in favour.\n*   The scheme involves a significant corporate restructuring, likely including a reduction of share capital.\n*   The company will now proceed to seek final approval for the scheme from the NCLT, Mumbai Bench.",{"company_name":166,"filing_date":205,"filing_source":9,"headline":206,"id":207,"stock_code":170,"summary_text":208},"2026-04-28T22:41:40.108000","Shareholders Approve Merger with JB Pharma","69f0ea850c6b4fb98a91e4d6","*   Shareholders have approved the Scheme of Amalgamation to merge J. B. Chemicals & Pharmaceuticals Limited (\"JB Pharma\") with Torrent Pharmaceuticals Limited.\n*   The resolution was passed with overwhelming support, receiving nearly 100% of the votes in favour from both promoter and public shareholders.\n*   This approval is a critical milestone for the merger, which now awaits final sanction from the National Company Law Tribunal (NCLT).\n*   The amalgamation is a major strategic step for inorganic growth, expected to enhance market presence and create operational synergies.",{"company_name":210,"filing_date":211,"filing_source":24,"headline":212,"id":213,"stock_code":170,"summary_text":214},"Torrent Pharmaceuticals Ltd","2026-04-28T22:41:40.055000","Shareholders Approve Merger with JB Chemicals & Pharmaceuticals","69f0ea82ec7f5de862c54253","*   Equity Shareholders have approved the Scheme of Amalgamation of J. B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals.\n*   The resolution was passed with an overwhelming majority, securing 100% of the valid votes by value in favour of the scheme.\n*   The meeting was convened on April 28, 2026, as directed by the National Company Law Tribunal (NCLT).\n*   The amalgamation is a material development for the company and now awaits final sanction from the NCLT.",{"company_name":216,"filing_date":217,"filing_source":24,"headline":218,"id":219,"stock_code":202,"summary_text":220},"Concord Enviro Systems Ltd","2026-04-28T22:36:40.190000","Shareholders Overwhelmingly Approve Restructuring Scheme","69f0e956890e096a6fc546e3","*   A special resolution for a \"Scheme of Arrangement\" between the company and its shareholders was passed with 99.9972% of votes in favour.\n*   The scheme involves a significant capital restructuring, likely including a payout to shareholders by utilizing share capital and\u002For securities premium.\n*   With shareholder approval secured, the company will now seek final sanction for the scheme from the National Company Law Tribunal (NCLT).",{"company_name":222,"filing_date":223,"filing_source":9,"headline":224,"id":225,"stock_code":226,"summary_text":227},"PCBL Chemical Limited","2026-04-28T22:36:39.054000","Important Update for Holders of Physical Shares","69f0e94af35e30561cff62d2","PCBL","- PCBL has announced a special window for shareholders to transfer and dematerialize physical shares that were purchased before April 1, 2019.\n- The filing also confirms the company's recent name change from \"PCBL Limited\" to \"PCBL Chemical Limited.\"\n- This action is a compliance requirement, and the official notice was published in *Business Standard* and *Aajkal* newspapers on April 28, 2026.",{"company_name":229,"filing_date":230,"filing_source":24,"headline":231,"id":232,"stock_code":226,"summary_text":233},"PCBL Chemical Ltd","2026-04-28T22:31:40.491000","Important Notice for Physical Shareholders","69f0e81d58d874434539c7dc","*   The company has announced a special 105-day window from **1st April 2026 to 15th July 2026** for the transfer and dematerialization of physical shares.\n*   This applies to securities purchased before 1st April 2019. This is a critical action for holders of physical share certificates.\n*   The filing also notes a recent name change from \"PCBL Limited\" to **\"PCBL Chemical Limited\"**.\n*   Public notices were published in the Business Standard and Aajkal newspapers on 28th April 2026.\n*   Shareholders are directed to contact the Registrar and Share Transfer Agent, **KFIN TECHNOLOGIES LIMITED**, for this process.",{"company_name":235,"filing_date":236,"filing_source":24,"headline":237,"id":238,"stock_code":239,"summary_text":240},"Uniworth Securities Ltd","2026-04-28T22:21:40.248000","Claims Exemption from Annual Secretarial Compliance Report","69f0e5bd5236ec998939c554","512408","*   The company has informed the stock exchange that it is not required to submit the Annual Secretarial Compliance Report for the financial year ending March 31, 2026.\n*   This is based on an exemption under SEBI regulations, as its Paid-up Capital (₹1.24 Cr) and Net Worth (₹1.91 Cr) are below the required thresholds.\n*   As a result, key corporate governance regulations (including those on board composition, audit committees, and related party transactions) are not applicable to the company.",{"company_name":242,"filing_date":243,"filing_source":9,"headline":244,"id":245,"stock_code":246,"summary_text":247},"Anlon Technology Solutions Limited","2026-04-28T22:21:39.623000","Board to Consider Fund Raising & Share Capital Increase","69f0e5b9f43b112c8d91dfb0","ANLON","*   A Board of Directors meeting is scheduled for May 03, 2026.\n*   The key agenda is to consider proposals for raising funds and increasing the company's authorised share capital.\n*   This strongly indicates a potential fund-raise through an equity issuance, which could lead to the dilution of existing shareholding.\n*   Investors should monitor the outcome of this meeting for specifics on the fund-raising plan, as it is a critical event.",{"company_name":249,"filing_date":250,"filing_source":9,"headline":251,"id":252,"stock_code":177,"summary_text":253},"Chennai Petroleum Corporation Limited","2026-04-28T22:21:39.586000","CPCL Declares Record Dividend & Reports Stellar Performance","69f0e5edec7f5de862c54243","*   \u003Cb>Record Dividend:\u003C\u002Fb> The Board recommended a final dividend of ₹54 per share, bringing the total for FY26 to a \u003Cb>highest-ever ₹62 per share\u003C\u002Fb>.\n*   \u003Cb>Strong Margins:\u003C\u002Fb> Reported a robust Gross Refining Margin (GRM) of \u003Cb>$13.75\u002Fbbl\u003C\u002Fb> for Q4, significantly outperforming benchmarks.\n*   \u003Cb>Operational Records:\u003C\u002Fb> Achieved the \u003Cb>highest-ever annual crude throughput of 11.71 MMT\u003C\u002Fb> (112% capacity) and record production of Diesel, Petrol, and LPG.\n*   \u003Cb>Strategic Growth:\u003C\u002Fb> Expanding with a ₹1,600 Cr Lube Oil Base Stock (LOBS) project and a ₹400 Cr plan for 300 retail outlets.\n*   \u003Cb>Geopolitical Risk:\u003C\u002Fb> Disclosed a temporary disruption of 30-40% of Middle East crude supply due to the closure of the Strait of Hormuz, highlighting supply chain vulnerability.\n*   \u003Cb>Bonus Issue:\u003C\u002Fb> Management noted a potential bonus issue will be considered by the Board at an \"appropriate time\" in response to a shareholder query.",{"company_name":191,"filing_date":255,"filing_source":9,"headline":256,"id":257,"stock_code":195,"summary_text":258},"2026-04-28T22:16:39.522000","Top Legal Executive Announces Resignation","69f0e490abd16353d2ff67af","*   Ms. Jagriti Bhattacharyya, the Executive Vice President - General Counsel and a Senior Management Personnel, has resigned.\n*   The resignation is for personal reasons and will be effective from 30th June 2026.\n*   The departure of a key management person represents a potential governance risk, and investors will be monitoring the company's succession plan.",{"company_name":260,"filing_date":261,"filing_source":9,"headline":262,"id":263,"stock_code":264,"summary_text":265},"Manaksia Aluminium Company Limited","2026-04-28T22:16:39.506000","Correction Issued: Company Clarifies It Is NOT a \"Large Corporate\"","69f0e490ec7f5de862c5423e","MANAKALUCO","*   The company has formally withdrawn a previous disclosure (letter no. Alum\u002F2026-27\u002F01) which it states was filed \"inadvertently and due to an administrative\u002Fclerical oversight.\"\n*   It has clarified that it does NOT meet the criteria to be classified as a \"Large Corporate\" under the SEBI framework.\n*   The company's outstanding borrowings are ₹89.09 Crores (as of March 31, 2026), below the ₹100 Crore threshold required for the classification.\n*   The company's highest credit rating is BBB+ (Stable), which is also below the 'AA' rating criteria for a Large Corporate.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The need to retract a formal regulatory filing due to an internal error highlights a potential weakness in the company's compliance and internal control procedures.",{"company_name":267,"filing_date":268,"filing_source":24,"headline":269,"id":270,"stock_code":271,"summary_text":272},"AVG Logistics Ltd","2026-04-28T22:11:40.578000","Board Approves Rights Issue to Raise up to ₹53 Crores","69f0e36aa157653c6639ca0b","AVG","• The Board of Directors has approved raising funds via a Rights Issue for an amount not exceeding ₹53 Crores.\n• A follow-up Board Meeting is scheduled for May 4, 2026, to finalize key details like the issue price, entitlement ratio, and record date.\n• Existing shareholders should note the potential for equity dilution for those who do not participate in the Rights Issue.\n• Investors should monitor the May 4th announcement for crucial details to assess the offer.",{"company_name":70,"filing_date":274,"filing_source":24,"headline":72,"id":275,"stock_code":55,"summary_text":276},"2026-04-28T22:11:40.358000","69f0e3695236ec998939c54b","\u003Cul>\n    \u003Cli>Equity Shareholders have approved the Scheme of Amalgamation with \u003Cb>Torrent Pharmaceuticals Limited\u003C\u002Fb> in a meeting convened by the National Company Law Tribunal (NCLT).\u003C\u002Fli>\n    \u003Cli>This is a highly material development that paves the way for the merger of the company into Torrent Pharmaceuticals.\u003C\u002Fli>\n    \u003Cli>Once the amalgamation is effective, J.B. Chemicals will cease to exist as a separate listed entity, and shareholders will likely receive shares of Torrent Pharmaceuticals.\u003C\u002Fli>\n    \u003Cli>The scheme remains subject to further regulatory approvals, including final sanction from the NCLT.\u003C\u002Fli>\n\u003C\u002Ful>",{"company_name":278,"filing_date":279,"filing_source":24,"headline":280,"id":281,"stock_code":195,"summary_text":282},"Firstsource Solutions Ltd","2026-04-28T22:11:40.275000","Key Management Change: General Counsel Resigns","69f0e36558d874434539c7c5","• Ms. Jagriti Bhattacharyya, Executive Vice President - General Counsel and Senior Management Personnel, has resigned.\n• The stated reason for her departure is personal, to \"look after my family.\"\n• Her resignation is effective from the close of business on 30th June 2026.\n• The departure is a material governance event, providing the company a two-month transition period to find a successor.",{"company_name":284,"filing_date":285,"filing_source":24,"headline":286,"id":287,"stock_code":288,"summary_text":289},"Reliance Power Ltd","2026-04-28T22:11:40.263000","Company Gains from Lapsed Warrants","69f0e362ecaa861d9491e272","RPOWER","• **Warrants Lapsed:** 21.82 crore outstanding warrants have expired after holders did not convert them into equity shares within the prescribed 18-month period.\n• **Financial Gain:** The company will retain the initial subscription amount paid by the warrant holders, which is now forfeited. This strengthens the company's reserves.\n• **Investor Impact:** The non-conversion suggests the stock price may have been unattractive for conversion, potentially signaling a lack of confidence from these specific investors.",{"company_name":291,"filing_date":292,"filing_source":24,"headline":293,"id":294,"stock_code":264,"summary_text":295},"Manaksia Aluminium Company Ltd","2026-04-28T22:11:40.197000","Admits Filing Error, Clarifies Corporate Status","69f0e36b890e096a6fc546c4","*   The company has formally withdrawn a previous disclosure (letter no. Alum\u002F2026-27\u002F01), stating it was filed \"inadvertently and due to an administrative\u002Fclerical oversight.\"\n*   It has clarified that it does NOT qualify as a \"Large Corporate\" under the SEBI framework as of March 31, 2026.\n*   The company's outstanding borrowings of ₹89.09 Crores are below the ₹100 Crore threshold for the \"Large Corporate\" classification.\n*   **Red Flag:** The need to withdraw a formal regulatory filing due to a clerical error highlights a potential weakness in the company's internal compliance and reporting controls.",{"company_name":297,"filing_date":298,"filing_source":9,"headline":299,"id":300,"stock_code":301,"summary_text":302},"Cadsys (India) Limited","2026-04-28T22:11:39.441000","Board Meeting Scheduled for May 4th with Vague Agenda","69f0e36af43b112c8d91dfa5","CADSYS","*   A meeting of the Board of Directors is scheduled for Monday, May 4, 2026.\n*   The agenda is vaguely listed only as \"Other business,\" which is unusual and provides no clarity to investors on the topics for discussion.\n*   This is considered a red flag; stakeholders should monitor for a follow-up filing after the meeting for details on any material decisions.",{"company_name":15,"filing_date":304,"filing_source":9,"headline":305,"id":306,"stock_code":19,"summary_text":307},"2026-04-28T22:06:41.772000","Board Approves ₹4.58 Crore Preferential Issue to Promoters & Others","69f0e2590c6b4fb98a91e4aa","- The Board approved raising up to ₹4.58 Crores by issuing 3,98,800 convertible warrants at a price of ₹115 each.\n- The Promoter and Promoter Group are the primary beneficiaries, proposed to be allotted ~91.3% of the issue, which will increase their stake.\n- This is a related-party transaction, as the Managing Director, Mr. Vipul Prakash, is also a proposed allottee.\n- The proposal is subject to shareholder approval via a Postal Ballot and will lead to equity dilution for existing shareholders.\n- The company has not disclosed the specific intended use of the funds to be raised.",{"company_name":51,"filing_date":309,"filing_source":9,"headline":53,"id":310,"stock_code":55,"summary_text":311},"2026-04-28T22:06:40.361000","69f0e23fabd16353d2ff679d","*   Equity Shareholders have approved the proposed Scheme of Amalgamation of J.B. Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited.\n*   The resolution was passed with the requisite majority at a National Company Law Tribunal (NCLT) convened meeting held on April 28, 2026.\n*   This approval is a major strategic step towards the consolidation of the two pharmaceutical companies.\n*   Detailed voting results, along with the Scrutinizer's Report, will be disclosed to the stock exchanges separately.",{"company_name":313,"filing_date":314,"filing_source":9,"headline":315,"id":316,"stock_code":288,"summary_text":317},"Reliance Power Limited","2026-04-28T22:06:40.272000","21.82 Crore Warrants Lapse, Averting Shareholder Dilution","69f0e27e5236ec998939c545","*   \u003Cb>Lapsing of Warrants:\u003C\u002Fb> 21.82 crore outstanding warrants have lapsed because they were not converted into equity shares within the 18-month period.\n*   \u003Cb>Financial Gain:\u003C\u002Fb> The subscription amount paid for these warrants has been forfeited to the company, resulting in a non-operating financial gain.\n*   \u003Cb>Shareholder Impact:\u003C\u002Fb> This prevents potential equity dilution that would have occurred upon conversion, which is positive for existing shareholders.\n*   \u003Cb>Market Signal:\u003C\u002Fb> The non-conversion suggests warrant holders found it economically unattractive to convert, often because the stock's market price was below the exercise price, potentially indicating weak market sentiment.",{"company_name":319,"filing_date":320,"filing_source":9,"headline":321,"id":322,"stock_code":323,"summary_text":324},"Pentagon Rubber Limited","2026-04-28T22:01:39.524000","[Governance Report Not Applicable for Q4 FY26]","69f0e107f43b112c8d91df9c","PENTAGON","*   The company has declared that it is not required to submit a Corporate Governance Report for the quarter ended March 31, 2026.\n*   This exemption is due to its status as a company listed on the EMERGE SME Platform of the National Stock Exchange (NSE).\n*   While many governance rules are waived, the company confirmed that regulations concerning Related Party Transactions will continue to apply.\n*   Shareholders will not receive the standard quarterly governance report, which reduces periodic transparency compared to main-board listed firms.",{"company_name":326,"filing_date":327,"filing_source":9,"headline":328,"id":329,"stock_code":330,"summary_text":331},"Five-Star Business Finance Limited","2026-04-28T21:56:39.574000","Leadership Continuity: Chief Risk Officer Re-appointed","69f0dfdca157653c6639c9f6","FIVESTAR","*   The Board of Directors has approved the re-appointment of Mr. Jayaraman S as the Chief Risk Officer (CRO).\n*   The CRO is designated as a Senior Management Personnel (SMP) of the company.\n*   The re-appointment is effective from June 1, 2026.\n*   This move ensures continuity in a key leadership position responsible for the company's risk management framework.",{"company_name":333,"filing_date":334,"filing_source":9,"headline":335,"id":336,"stock_code":337,"summary_text":338},"Piccadily Agro Industries Limited","2026-04-28T21:56:39.571000","FY26 Revenue Soars 28% to ₹1,143 Crore, Plans to Demerge Sugar Business","69f0dff15236ec998939c53c","PICCADIL","*   **Strong Annual Growth**: Consolidated revenue for FY26 grew 28% YoY to ₹1,143 crore, with Profit Before Tax (PBT) up 33% to ₹192 crore.\n*   **Alco-Bev Division Shines**: The Distillery (Alco-bev) division was the primary growth driver, with its revenue surging 42.1% YoY to ₹908 crore.\n*   **Impressive Q4 Results**: Q4 FY26 revenue jumped 67% YoY to ₹250 crore, led entirely by the strong performance of the Alco-bev division.\n*   **Strategic Demerger**: The company has initiated a demerger to separate its Sugar division. The goal is to become a pure-play alco-beverage company by the end of FY27.\n*   **Future Catalyst**: A new manufacturing facility in Chhattisgarh is set to begin monetisation from May 2026, which is expected to accelerate growth.",{"company_name":340,"filing_date":341,"filing_source":9,"headline":342,"id":343,"stock_code":344,"summary_text":345},"Maruti Suzuki India Limited","2026-04-28T21:56:39.548000","FY26 Investor Call Audio Recording Available","69f0dfd8f43b112c8d91df97","MARUTI","*   The audio recording of the investor call held on April 28, 2026, is now available on the company's website.\n*   This call pertains to the annual financial results for the year ended March 31, 2026.\n*   This filing is a routine compliance update to inform stakeholders about the recording's availability.\n*   No new financial data or material information is disclosed in this specific document.",{"company_name":347,"filing_date":348,"filing_source":24,"headline":349,"id":350,"stock_code":351,"summary_text":352},"Piramal Pharma Ltd","2026-04-28T21:51:41.515000","FY26 Results: Swings to Net Loss on Impairment, but Operating Cash Flow Jumps 85%","69f0def4c9cbead9b3c5449a","PPLPHARMA","*   Reports a consolidated net loss of ₹325.94 Cr for FY26, a significant swing from a net profit of ₹91.13 Cr in FY25.\n*   The loss was primarily driven by an exceptional item of ₹196.14 Cr, which includes a ₹175.82 Cr impairment charge on an intangible asset under development.\n*   Revenue from operations saw a marginal decline of 3.1% to ₹8,869.08 Cr.\n*   Despite the reported loss, Cash Flow from Operations was very strong, increasing by 85.2% to ₹1,652.59 Cr.\n*   A subsidiary completed the acquisition of the Kenalog® brand from Bristol Myers Squibb for an upfront consideration of USD 35 million and contingent payments up to USD 65 million.\n*   The Board approved the re-appointment of Chairperson Nandini Piramal, Executive Director Peter DeYoung, and other key personnel, subject to shareholder approval.",{"company_name":347,"filing_date":354,"filing_source":24,"headline":355,"id":356,"stock_code":351,"summary_text":357},"2026-04-28T21:51:41.335000","FY26 Results: Swings to Net Loss, Acquires Kenalog® from BMS","69f0dee15236ec998939c538","*   \u003Cb>FY26 Financials:\u003C\u002Fb> The company reported a consolidated Net Loss of ₹(325.94) Cr, a sharp decline from a Net Profit of ₹91.13 Cr in FY25.\n*   \u003Cb>Key Driver for Loss:\u003C\u002Fb> Results were heavily impacted by exceptional items, including a major impairment charge of ₹175.82 Cr on an intangible asset.\n*   \u003Cb>Major Acquisition:\u003C\u002Fb> A subsidiary completed the acquisition of the Kenalog® brand portfolio from Bristol Myers Squibb for an upfront consideration of USD 35 million.\n*   \u003Cb>Operating Cash Flow:\u003C\u002Fb> Despite the loss, Net Cash from Operating Activities improved significantly to ₹1,652.59 Cr for FY26 (vs. ₹892.30 Cr in FY25).\n*   \u003Cb>Management Update:\u003C\u002Fb> Appointed Mr. Maneesh Sharma as the new Company Secretary & Compliance Officer, effective 29 April 2026.",{"company_name":347,"filing_date":359,"filing_source":24,"headline":360,"id":361,"stock_code":351,"summary_text":362},"2026-04-28T21:51:41.259000","Posts FY26 Loss of ₹326 Cr Driven by Impairment, Acquires Kenalog® Brand","69f0def8ecaa861d9491e25b","*   \u003Cb>FY26 Financials:\u003C\u002Fb> Reported a consolidated net loss of ₹325.94 crore, a sharp reversal from a profit of ₹91.13 crore in FY25.\n*   \u003Cb>Key Driver for Loss:\u003C\u002Fb> The result was heavily impacted by a ₹175.82 crore impairment charge on an intangible asset under development.\n*   \u003Cb>Strategic Acquisition:\u003C\u002Fb> Acquired the Kenalog® brand from Bristol Myers Squibb for an upfront payment of $35 million plus contingent considerations.\n*   \u003Cb>Strong Cash Flow:\u003C\u002Fb> Despite the loss, generated strong Net Cash from Operating Activities of ₹1,652.59 crore at the consolidated level.\n*   \u003Cb>Governance:\u003C\u002Fb> The Board approved the re-appointment of key leadership, including Chairperson Ms. Nandini Piramal and Executive Director Mr. Peter DeYoung.\n*   \u003Cb>Dividend:\u003C\u002Fb> No new dividend has been recommended for the financial year ended March 31, 2026.",{"company_name":364,"filing_date":365,"filing_source":24,"headline":366,"id":367,"stock_code":337,"summary_text":368},"Piccadily Agro Industries Ltd","2026-04-28T21:51:40.885000","FY26 Revenue Jumps 28%, Initiates Demerger of Sugar Business","69f0dec658d874434539c7a9","• \u003Cb>Record FY26 Performance:\u003C\u002Fb> Consolidated Revenue hit ₹1,143 crore (+28% YoY), with Profit Before Tax at ₹192 crore (+33% YoY).\n• \u003Cb>Distillery Drives Growth:\u003C\u002Fb> The Alco-bev segment's revenue surged 42.1% to ₹908 crore, driven by strong demand for premium brands like Indri.\n• \u003Cb>Strategic Demerger:\u003C\u002Fb> The company is separating its Sugar division to become a pure-play alco-beverage company, aiming to unlock shareholder value.\n• \u003Cb>Positive Outlook:\u003C\u002Fb> A new Chhattisgarh facility will begin monetization in May 2026, expected to further accelerate growth.",{"company_name":370,"filing_date":371,"filing_source":24,"headline":372,"id":373,"stock_code":330,"summary_text":374},"Five-Star Business Finance Ltd","2026-04-28T21:51:40.852000","Board Approves Update to Code of Fair Disclosure","69f0dec4a157653c6639c9ed","*   The Board of Directors has approved amendments to the company's \"Code of Fair Disclosure\" to comply with SEBI's insider trading regulations.\n*   The decision was made at a board meeting held on April 28, 2026.\n*   This is a routine governance update and does not indicate any material change in the company's business operations or financial health.\n*   The amended policy is available on the company's investor relations website.",{"company_name":376,"filing_date":377,"filing_source":24,"headline":378,"id":379,"stock_code":344,"summary_text":380},"Maruti Suzuki India Ltd","2026-04-28T21:51:40.765000","Investor Call Audio Recording Now Available","69f0debdf35e30561cff62af","*   Maruti Suzuki has uploaded the audio recording of its investor call held on April 28, 2026.\n*   The call discussed the annual financial results for the financial year ending March 31, 2026.\n*   The recording is available on the company's corporate website, enhancing transparency for shareholders.\n*   This filing is a procedural compliance update under SEBI regulations and does not contain any new financial or operational data.",{"company_name":382,"filing_date":383,"filing_source":9,"headline":384,"id":385,"stock_code":386,"summary_text":387},"Prozone Realty Limited","2026-04-28T21:51:40.407000","Invests ₹24 Crore to Acquire 17.5% Stake in Gajaanan Property Developers","69f0deb6abd16353d2ff677f","PROZONER","• \u003Cb>Transaction:\u003C\u002Fb> The company will acquire a 17.507% stake in Gajaanan Property Developers Private Limited (GPDPL) for a total consideration of ₹24 Crore in cash.\n• \u003Cb>Strategic Goal:\u003C\u002Fb> This acquisition is a strategic move to expand into high-income yielding assets and gain access to a \"high-potential land asset\" held by GPDPL.\n• \u003Cb>Timeline:\u003C\u002Fb> The transaction is expected to be completed within 180 days.\n• \u003Cb>Key Risk:\u003C\u002Fb> The target company (GPDPL) has demonstrated highly volatile turnover in the past three financial years, which is a key risk factor for investors to monitor.",{"company_name":389,"filing_date":390,"filing_source":9,"headline":391,"id":392,"stock_code":393,"summary_text":394},"Sri Lotus Developers and Realty Limited","2026-04-28T21:51:40.203000","Receives ₹10 Crore GST Show Cause Notice","69f0dec1bf8f716f13ff65ab","544469","*   The company received a Show Cause Notice (SCN) from GST authorities alleging a total liability of **₹10,00,40,314** (approx. ₹10 Crore).\n*   The demand relates to alleged discrepancies for FY 2020-21, 2021-22, and 2023-24, and includes tax, interest, and penalty.\n*   Sri Lotus has already paid the entire alleged tax component of **₹3.65 Crore** under protest.\n*   The company will contest the notice and states it expects \"no material impact,\" despite a potential remaining liability of **₹6.35 Crore** if the case is lost.",{"company_name":382,"filing_date":396,"filing_source":9,"headline":397,"id":398,"stock_code":386,"summary_text":399},"2026-04-28T21:51:40.167000","Prozone Realty to Sell Mall Business for ₹1,242.50 Crores","69f0deb7f43b112c8d91df91","*   The company has announced the sale of its mall business, held under the subsidiary `Kruti Multitrade Private Limited`, to `Inorbit Malls Private Limited`.\n*   The deal is valued at an aggregate gross consideration of up to approximately **₹1,242.50 Crores**, payable in cash.\n*   This strategic sale is subject to shareholder approval as per SEBI regulations.\n*   The transaction is expected to be completed by 25 August 2026.",{"company_name":401,"filing_date":402,"filing_source":9,"headline":403,"id":404,"stock_code":271,"summary_text":405},"AVG Logistics Limited","2026-04-28T21:51:40.135000","Board to Consider Fundraising via Rights Issue","69f0debaec7f5de862c54225","*   A Board Meeting is scheduled for May 04, 2026, to consider and approve a fundraising proposal.\n*   The primary method under consideration is a Rights Issue.\n*   Key terms like the issue price, entitlement ratio, and record date will be determined at the meeting.\n*   The proposal is subject to receiving necessary regulatory and stock exchange approvals.",{"company_name":326,"filing_date":407,"filing_source":9,"headline":408,"id":409,"stock_code":330,"summary_text":410},"2026-04-28T21:51:40.116000","Recommends Final Dividend of ₹2\u002FShare","69f0deb60c6b4fb98a91e48c","*   The Board of Directors has recommended a final dividend of ₹2 per equity share for the financial year 2025-26.\n*   The record date to determine shareholder eligibility for the dividend is set for July 31, 2026.\n*   This dividend is subject to the approval of shareholders at the upcoming Annual General Meeting (AGM).",{"company_name":382,"filing_date":412,"filing_source":9,"headline":413,"id":414,"stock_code":386,"summary_text":415},"2026-04-28T21:46:39.660000","Restructuring Alert: Subsidiary to Sell Land Assets for ₹44 Crore","69f0dd890c6b4fb98a91e482","*   Prozone Realty announced a proposed sale of land assets from its wholly-owned subsidiary, Alliance Mall Developers, to another wholly-owned subsidiary, Prozone Horizons.\n*   The transaction is valued at approximately ₹ 44 Crores and is part of an internal corporate restructuring.\n*   This is a material transaction under SEBI Regulation 37A, which requires prior approval from shareholders via a special resolution.\n*   The company is in the process of obtaining this shareholder approval, with the transaction expected to be completed by August 25, 2026.",{"company_name":382,"filing_date":417,"filing_source":9,"headline":418,"id":419,"stock_code":386,"summary_text":420},"2026-04-28T21:46:39.652000","Prozone Realty to Divest Empire Mall in a ₹1,242.50 Crore Deal","69f0dd8aec7f5de862c5421f","*   Prozone has announced the sale of its entire undertaking in its subsidiary, **Empire Mall Private Limited**, to Inorbit Malls Private Limited.\n*   The transaction is valued at an aggregate gross consideration of up to **₹ 1,242.50 Crores** in cash.\n*   This is a highly material event, as the subsidiary contributes **35.09%** of the company's total turnover and **31.57%** of its net worth.\n*   The sale is subject to shareholder approval and is expected to be completed by 25-Aug-2026.",{"company_name":382,"filing_date":422,"filing_source":9,"headline":423,"id":424,"stock_code":386,"summary_text":425},"2026-04-28T21:46:39.641000","Announces Internal Asset Sale Valued at ~₹13 Crores","69f0dd9b890e096a6fc546a5","*   Prozone is restructuring by selling \"Land Assets\" from its subsidiary, Empire Mall Pvt. Ltd., to another wholly-owned subsidiary, Hagwood Commercial Developers Pvt. Ltd.\n*   The transaction is valued at approximately ₹13 Crores in cash and is expected to be completed by August 25, 2026.\n*   The company is seeking shareholder approval for this related-party transaction.\n*   \u003Cb>Red Flag:\u003C\u002Fb> A significant data inconsistency was noted in the filing. The asset's stated turnover contribution (0.3157%) is mathematically inconsistent with the provided figures, which calculate to 25.48%.",{"company_name":382,"filing_date":427,"filing_source":9,"headline":428,"id":429,"stock_code":386,"summary_text":430},"2026-04-28T21:46:39.602000","Announces Sale of Major Subsidiary for ~₹1,242.50 Crores","69f0de38a157653c6639c9e9","*   The company will sell its subsidiary, **Alliance Mall Developers Co Private Limited**, to **Inorbit Malls (India) Private Limited**.\n*   The deal is valued at an aggregate gross consideration of up to **approx. ₹1,242.50 Crores**, to be paid in cash.\n*   This is a major divestment, as the subsidiary accounts for **33.16% of the company's consolidated turnover** and **22.26% of its net worth**.\n*   The transaction is subject to shareholder approval and is expected to be completed by 25 August 2026.",{"company_name":347,"filing_date":432,"filing_source":24,"headline":433,"id":434,"stock_code":351,"summary_text":435},"2026-04-28T21:36:40.230000","Reports ₹326 Cr Net Loss for FY26; Acquires Kenalog® Brand from BMS","69f0db5df35e30561cff62a6","*   Reports a consolidated Net Loss of ₹325.94 Crores for FY26, a sharp decline from a Net Profit of ₹91.13 Crores in FY25.\n*   The loss was primarily driven by a one-time exceptional charge of ₹196.14 Crores, which includes a ₹175.82 Crore impairment on an R&D asset.\n*   Despite the loss, Net Cash from Operating Activities grew by a strong 85% to ₹1,652.59 Crores, indicating healthy underlying cash generation.\n*   Announced the acquisition of the Kenalog® brand from Bristol Myers Squibb for an upfront payment of $35 million and up to $65 million in contingent payments.\n*   The Board approved the re-appointment of Chairperson Nandini Piramal and Executive Director Peter DeYoung. Mr. Maneesh Sharma was appointed as the new Company Secretary.",{"company_name":291,"filing_date":437,"filing_source":24,"headline":438,"id":439,"stock_code":264,"summary_text":440},"2026-04-28T21:31:41.652000","Responds to Exchange on Share Price Movement","69f0da24f35e30561cff62a0","*   The company has issued a clarification to the NSE & BSE in response to a query about the recent significant movement in its share price.\n*   Manaksia Aluminium states it is in full compliance with SEBI regulations and has been promptly disclosing all material information.\n*   Crucially, the company confirms there is no undisclosed event, information, or announcement that would have a bearing on the stock's price or volume.\n*   The filing suggests the price volatility may be driven by market speculation or other external factors, not by any undisclosed corporate developments.",{"company_name":442,"filing_date":443,"filing_source":24,"headline":444,"id":445,"stock_code":446,"summary_text":447},"Mitshi India Ltd","2026-04-28T21:31:41.606000","FY26 Profit Plummets, Auditor Raises Major Red Flags","69f0da3abf8f716f13ff6596","523782","*   \u003Cb>FY26 Financials:\u003C\u002Fb> Net Profit plunged 80.6% to ₹0.69 Lakhs, while revenue fell 39.4% year-over-year.\n*   \u003Cb>Auditor's Qualified Opinion:\u003C\u002Fb> A major red flag was raised as the auditor issued a \"Qualified Opinion,\" citing issues verifying substantial cash transactions and an inability to confirm key account balances (receivables, payables, loans).\n*   \u003Cb>Negative Operating Cash Flow:\u003C\u002Fb> The company reported negative cash from operations for the second consecutive year, funding its activities through new borrowings.\n*   \u003Cb>Weak Balance Sheet:\u003C\u002Fb> The company's net worth is eroded, with negative reserves of ₹(607.21) Lakhs. The auditor could not confirm trade receivables, which make up 68% of total assets.",{"company_name":449,"filing_date":450,"filing_source":24,"headline":451,"id":452,"stock_code":453,"summary_text":454},"MSR India Ltd","2026-04-28T21:31:41.524000","Director Resigns, Company Submits Flawed Filing","69f0da11ec7f5de862c5420f","508922","*   Mr. Boddu Sri Ram Chowdary has resigned as an Independent Director, effective from the close of business hours on April 28, 2026, citing personal reasons.\n*   \u003Cb>Red Flag:\u003C\u002Fb> The official filing contains a significant error. A mandatory annexure incorrectly names a \"Mr. Arjun Kumar Saladi\" instead of the resigning director, Mr. Chowdary.\n*   This material error indicates a lack of procedural diligence and poor internal controls within the company's compliance function, undermining the accuracy of its disclosures.",{"company_name":370,"filing_date":456,"filing_source":24,"headline":457,"id":458,"stock_code":330,"summary_text":459},"2026-04-28T21:31:41.392000","FY26 Results: NPAs Double, Hitting Profit Growth","69f0da4fecaa861d9491e246","• \u003Cb>Profit Stalls:\u003C\u002Fb> Profit After Tax (PAT) grew just 2% YoY to ₹10,988 Mn, as a massive 143% surge in credit costs (provisions) wiped out income gains.\n• \u003Cb>Asset Quality Worsens:\u003C\u002Fb> Gross NPAs nearly doubled to 3.37% from 1.79% a year ago, indicating significant stress in the loan book.\n• \u003Cb>Provisioning Red Flag:\u003C\u002Fb> Despite rising NPAs, the company reduced its Provision Coverage Ratio on these bad loans from 51.3% down to 41.4%.\n• \u003Cb>Slowing Momentum:\u003C\u002Fb> Loan disbursements declined by 6% YoY, though Assets Under Management (AUM) still grew by 11% to ₹132,246 Mn.\n• \u003Cb>Management Outlook:\u003C\u002Fb> Looking ahead, management guides for a return to ~20% AUM growth for FY27, signaling confidence in a recovery.",{"company_name":347,"filing_date":461,"filing_source":24,"headline":462,"id":463,"stock_code":351,"summary_text":464},"2026-04-28T21:31:41.373000","Swings to Net Loss in FY26, Acquires Kenalog® Brand","69f0da32c9cbead9b3c54484","*   **FY26 Results:** Reported a consolidated net loss of **₹325.94 Cr**, a sharp swing from a profit of ₹91.13 Cr in FY25. The loss was driven by a **₹196.14 Cr exceptional item**, including a major impairment charge.\n*   **Revenue & Debt:** Revenue from operations declined by **3.1% YoY** to ₹8,869.08 Cr, while total borrowings increased to **₹5,495.48 Cr**.\n*   **Brand Acquisition:** Post year-end, a subsidiary acquired the **Kenalog® brand** from Bristol Myers Squibb for an upfront payment of USD 35 million.\n*   **Positive Cash Flow:** Despite the net loss, the company generated strong Net Cash from Operating Activities of **₹1,652.59 Cr**, a significant improvement from the previous year.\n*   **Governance:** Approved the re-appointment of key directors, including the Chairperson, and appointed a new Company Secretary.",{"company_name":347,"filing_date":466,"filing_source":24,"headline":467,"id":468,"stock_code":351,"summary_text":469},"2026-04-28T21:31:41.273000","Piramal Pharma Reports ₹326 Cr Net Loss for FY26, Announces Acquisition & Leadership Updates","69f0da24890e096a6fc5468e","*   **Financials:** Reported a consolidated net loss of ₹(325.94) Crores for FY26, a sharp reversal from a profit of ₹91.13 Crores in FY25. Basic EPS fell to ₹(2.46) from ₹0.69.\n*   **Key Driver:** The loss was primarily driven by exceptional items, including a significant impairment charge of ₹175.82 Crores on an intangible asset under development.\n*   **Strategic Acquisition:** A subsidiary completed the acquisition of the Kenalog® brand portfolio from Bristol Myers Squibb on April 1, 2026, for an upfront consideration of USD 35 million and up to USD 65 million in contingent payments.\n*   **Leadership Continuity:** The Board approved the re-appointment of Ms. Nandini Piramal (Chairperson) and Mr. Peter DeYoung (Executive Director) for new terms, subject to shareholder approval.\n*   **KMP Change:** Appointed Mr. Maneesh Sharma as the new Company Secretary and Compliance Officer, effective April 29, 2026.",{"company_name":471,"filing_date":472,"filing_source":24,"headline":473,"id":474,"stock_code":475,"summary_text":476},"Bandhan Bank Ltd","2026-04-28T21:31:41.178000","Q4 & FY26 Earnings Call Recording Published","69f0da0da157653c6639c9d0","BANDHANBNK","*   The audio recordings for the Press Conference and Earnings Call held on April 28, 2026, are now available.\n*   These calls discuss the audited financial results for the quarter (Q4) and financial year ended March 31, 2026.\n*   Recordings can be accessed on the bank's corporate website under the \"Investor Presentation \u002F Audio or Video Recordings \u002F Transcript\" section.\n*   This filing is a procedural notification and does not contain financial results; investors should refer to the recordings for performance details.",{"company_name":347,"filing_date":478,"filing_source":24,"headline":479,"id":480,"stock_code":351,"summary_text":481},"2026-04-28T21:31:40.983000","FY26 Results: CDMO Slump Drives Net Loss, But Management Guides for Strong Recovery","69f0da2a5236ec998939c528","*   \u003Cb>Financials:\u003C\u002Fb> FY26 revenue fell 3% YoY to ₹8,869 Cr. The company reported a Net Loss of ₹(326) Cr, largely due to a ₹196 Cr impairment charge on an intangible asset.\n*   \u003Cb>Segment Performance:\u003C\u002Fb> The CDMO business (largest segment) saw a 10% revenue decline. However, the Consumer Healthcare (PCH) segment grew a strong 17%, and Complex Hospital Generics (CHG) grew 3%.\n*   \u003Cb>Regulatory Strength:\u003C\u002Fb> Maintained an excellent compliance record, successfully clearing 38 regulatory inspections, including 3 from the USFDA, with a 'Zero OAI' (Official Action Indicated) track record.\n*   \u003Cb>Outlook:\u003C\u002Fb> Management termed FY26 a \"transitional year\" and provided a strong positive outlook for FY27, expecting a return to growth in revenue, EBITDA, and PAT.",{"company_name":347,"filing_date":483,"filing_source":24,"headline":484,"id":485,"stock_code":351,"summary_text":486},"2026-04-28T21:31:40.889000","[Posts FY26 Net Loss Amid CDMO Decline; Eyes FY27 Rebound]","69f0da2c58d874434539c793","• Reported a consolidated Net Loss of ₹326 Cr for FY26, a sharp reversal from a ₹91 Cr profit in FY25, partly due to a ₹196 Cr impairment charge.\n• The largest segment, CDMO, saw revenue decline 10% YoY, impacted by industry-wide destocking.\n• Piramal Consumer Healthcare (PCH) was a bright spot, growing 17% YoY, driven by its \"Power Brands\" and e-commerce.\n• Completed the strategic acquisition of the Kenalog® brand to strengthen its Complex Hospital Generics (CHG) portfolio.\n• Management described FY26 as a \"transitional year\" and expects a return to growth in FY27.",{"company_name":442,"filing_date":488,"filing_source":24,"headline":489,"id":490,"stock_code":446,"summary_text":491},"2026-04-28T21:31:40.803000","Claims Exemption from Related Party Transaction Reporting","69f0da0eabd16353d2ff675f","*   The company has declared it is not required to submit the Related Party Transaction (RPT) report for the financial year ending March 31, 2026.\n*   This exemption is claimed because its Paid-up Capital (₹8.80 Cr) and Net Worth (₹2.72 Cr) are below the SEBI regulatory thresholds.\n*   For shareholders, this means reduced transparency into transactions between the company and its promoters or other related entities for this period.",{"company_name":493,"filing_date":494,"filing_source":24,"headline":495,"id":496,"stock_code":497,"summary_text":498},"Tata Motors Passenger Vehicles Ltd","2026-04-28T21:31:40.792000","Board Meeting on May 14 to Approve FY26 Results & Consider Dividend","69f0da09f43b112c8d91df7b","TATAMOTORS","• A Board of Directors meeting is scheduled for Thursday, May 14, 2026.\n• The agenda includes approving the audited financial results for the quarter and year ended March 31, 2026.\n• The Board will also consider recommending a dividend for the financial year 2025-26.\n• The filing highlights a significant corporate name change from \"Tata Motors Limited\" to \"Tata Motors Passenger Vehicles Limited\".",{"company_name":500,"filing_date":501,"filing_source":9,"headline":502,"id":503,"stock_code":504,"summary_text":505},"Life Insurance Corporation Of India","2026-04-28T21:31:39.668000","Board Update: Two Independent Directors Cease Office","69f0da090c6b4fb98a91e465","LICI","*   Mr. Vinod Kumar Verma and Mr. Ranjan Sharma have ceased to be Non-Executive Independent Directors, effective April 28, 2026.\n*   The reason for cessation is the procedural end of their term (\"co terminus basis\") and is not due to any disagreement with the company.\n*   This is a routine governance event, and the key consideration for investors is the timely appointment of replacements to ensure board compliance.",{"company_name":260,"filing_date":507,"filing_source":9,"headline":508,"id":509,"stock_code":264,"summary_text":510},"2026-04-28T21:31:39.654000","Addresses Significant Share Price Movement","69f0da08f35e30561cff629e","*   In response to a query from the stock exchanges (NSE & BSE), the company has issued a clarification regarding the recent significant movement in its share price.\n*   Manaksia Aluminium states that there is **no undisclosed event, information, or announcement** that could have a material bearing on the stock's price or volume.\n*   The company affirms it has complied with all disclosure requirements and has already shared all price-sensitive information.\n*   This implies the recent price volatility may be driven by market speculation or rumors, rather than any undisclosed fundamental development within the company.",{"company_name":512,"filing_date":513,"filing_source":9,"headline":514,"id":515,"stock_code":516,"summary_text":517},"Onesource Specialty Pharma Limited","2026-04-28T21:26:39.708000","Secures Key EU GMP Certification, Unlocking European Market Access","69f0d8d9f35e30561cff6298","ONESOURCE","• **Received EU Good Manufacturing Practice (EU GMP) certification** for its Sterile Product Division (SPD) facility in Bangalore, a material positive development for shareholders.\n• This approval **enables the company to supply its sterile products to the European Union**, opening up significant new revenue streams.\n• The certification validates the company's high-quality manufacturing standards, adding to existing approvals from major regulators like the **US-FDA, Health Canada, ANVISA (Brazil), and TGA (Australia)**.\n• This milestone positions the company as a credible global player in the pharmaceutical contract development and manufacturing (CDMO) space.",{"company_name":519,"filing_date":520,"filing_source":9,"headline":521,"id":522,"stock_code":351,"summary_text":523},"Piramal Pharma Limited","2026-04-28T21:26:39.509000","Swings to ₹326 Cr Loss in FY26, Cites Impairment & Acquires New Brand","69f0d9020c6b4fb98a91e45f","*   \u003Cb>Profit to Loss:\u003C\u002Fb> The company reported a consolidated Net Loss of ₹325.94 crore for FY26, a sharp reversal from a Net Profit of ₹91.13 crore in FY25.\n*   \u003Cb>Exceptional Items:\u003C\u002Fb> The loss was driven by a significant exceptional charge of ₹196.14 crore, primarily due to a ₹175.82 crore impairment on an intangible asset under development.\n*   \u003Cb>Strategic Acquisition:\u003C\u002Fb> Post year-end, a subsidiary acquired the Kenalog® brand from Bristol Myers Squibb for an upfront consideration of USD 35 million.\n*   \u003Cb>Standalone Performance:\u003C\u002Fb> In contrast, the standalone entity reported a profit of ₹700.01 crore, significantly boosted by a non-operating forex gain of ₹381.82 crore.\n*   \u003Cb>KMP Change:\u003C\u002Fb> Appointed Mr. Maneesh Sharma as the new Company Secretary and Compliance Officer, effective April 29, 2026.",{"company_name":519,"filing_date":525,"filing_source":9,"headline":526,"id":527,"stock_code":351,"summary_text":528},"2026-04-28T21:26:39.329000","Posts FY26 Loss Driven by Impairment, Acquires Kenalog® Brand","69f0d8f75236ec998939c522","*   Reports a consolidated net loss of ₹325.94 Cr for FY26, a sharp reversal from a ₹91.13 Cr profit in FY25.\n*   The loss was driven by a significant one-time impairment charge of ₹175.82 Cr on an intangible asset under development.\n*   Announced the acquisition of the Kenalog® brand from Bristol Myers Squibb for an upfront consideration of $35 million, with up to $65 million in contingent payments.\n*   The Board approved the re-appointment of key leadership, including Chairperson Ms. Nandini Piramal and Executive Director Mr. Peter DeYoung.\n*   Statutory auditors issued an 'Unmodified Opinion' (a clean report) on the annual financial statements.",{"company_name":519,"filing_date":530,"filing_source":9,"headline":531,"id":532,"stock_code":351,"summary_text":533},"2026-04-28T21:26:39.291000","Reports Significant FY26 Loss, Acquires Kenalog® Brand from BMS","69f0d8f4a157653c6639c9c7","*   The company swung to a consolidated net loss of ₹(325.94) Crores for FY26, a sharp decline from a profit of ₹91.13 Crores in the previous year.\n*   The loss was driven by exceptional items, including a significant impairment charge of ₹175.82 Crores on an intangible asset.\n*   Post-year-end, a subsidiary acquired the Kenalog® brand from Bristol Myers Squibb for an upfront payment of USD 35 million, plus up to USD 65 million in milestones.\n*   The Board approved the re-appointment of several key directors, including Chairperson Nandini Piramal, and appointed Mr. Maneesh Sharma as the new Company Secretary.\n*   Despite the net loss, the statutory auditors issued an unmodified opinion on the financial results.",{"company_name":535,"filing_date":536,"filing_source":9,"headline":537,"id":538,"stock_code":475,"summary_text":539},"Bandhan Bank Limited","2026-04-28T21:26:39.099000","Q4 & FY26 Earnings Call Audio Now Available","69f0d8d6ec7f5de862c5420a","• The bank has published the audio recordings of its earnings call and press conference for the quarter (Q4) and financial year ended March 31, 2026.\n• This filing is a procedural notification and does not contain financial results, but provides a link to where the results were discussed.\n• The disclosure is made to comply with SEBI's Regulation 30.\n• Stakeholders can access the recordings on the bank's website to hear management's discussion on performance.",{"company_name":541,"filing_date":542,"filing_source":9,"headline":543,"id":544,"stock_code":545,"summary_text":546},"GHCL Textiles Limited","2026-04-28T21:21:40.794000","Promoter Entity Confirms No New Undisclosed Share Pledges","69f0d7d4abd16353d2ff6750","GHCLTEXTIL","*   A promoter entity, Anurag Trading Leasing and Investment Company, filed a declaration regarding its shareholding for the financial year ended March 31, 2026.\n*   The promoter confirmed that no new, undisclosed encumbrances (like share pledges) were created on their shares in GHCL Textiles during this period.\n*   This filing provides transparency to shareholders, confirming no increase in promoter pledging, which is often viewed as a risk factor by investors.",{"company_name":519,"filing_date":548,"filing_source":9,"headline":549,"id":550,"stock_code":351,"summary_text":551},"2026-04-28T21:21:40.423000","Reports Net Loss for FY26 Amid CDMO Weakness, Eyes FY27 Rebound","69f0d7e45236ec998939c51e","*   \u003Cb>FY26 Financials:\u003C\u002Fb> Reported a consolidated net loss of ₹(326) Crores, a sharp decline from a profit of ₹91 Crores in FY25. Consolidated revenue was down 3% YoY to ₹8,869 Crores.\n*   \u003Cb>Segment Performance:\u003C\u002Fb> The largest segment, CDMO, saw a 10% revenue decline due to industry destocking. However, the Consumer Healthcare (PCH) segment grew strongly by 17% YoY.\n*   \u003Cb>Impairment Charge:\u003C\u002Fb> An exceptional item of ₹196 Crores was recorded as an impairment loss on intangible assets, significantly impacting profitability.\n*   \u003Cb>Management Outlook:\u003C\u002Fb> Management termed FY26 a \"transitional year\" and guided for a return to growth in FY27, with accelerated growth in EBITDA and PAT.\n*   \u003Cb>Regulatory Success:\u003C\u002Fb> Maintained a strong compliance record, clearing 38 regulatory inspections (including 3 from US FDA) with a \"Zero OAI\" (Official Action Indicated) track record.",{"company_name":541,"filing_date":553,"filing_source":9,"headline":554,"id":555,"stock_code":545,"summary_text":556},"2026-04-28T21:21:40.375000","Promoter Group Confirms No Share Encumbrance for FY26","69f0d7bb58d874434539c770","*   The promoter group, led by Neelabh Dalmia, has declared that they have **not created any new encumbrances** (like pledging shares) on their holdings for the financial year ended March 31, 2026.\n*   This is a mandatory annual declaration filed with the stock exchanges under **SEBI's Takeover Regulations**.\n*   The absence of share pledging is a **positive signal for shareholders**, indicating promoter financial stability and reducing the risk of a forced sale of their shares.",{"company_name":558,"filing_date":559,"filing_source":9,"headline":560,"id":561,"stock_code":562,"summary_text":563},"Muthoot Finance Limited","2026-04-28T21:21:40.280000","Promoters Confirm Zero Share Pledges for FY26","69f0d7a6ecaa861d9491e236","MUTHOOTFIN","*   The Promoter, Mr. George Alexander Muthoot, has submitted an annual declaration for the financial year ended March 31, 2026.\n*   The declaration confirms that the promoter group has **not** created any encumbrances (pledges) on their shares of Muthoot Finance Limited.\n*   This is considered a positive governance signal, as it mitigates the risk of forced selling of promoter shares.\n*   The filing provides assurance to shareholders regarding the financial stability of the promoter group.",{"company_name":558,"filing_date":565,"filing_source":9,"headline":566,"id":567,"stock_code":562,"summary_text":568},"2026-04-28T21:21:40.137000","Promoter Stability Update: No New Share Encumbrances","69f0d7ae0c6b4fb98a91e457","*   A Promoter has declared that **no new encumbrances** (e.g., pledging of shares) were created on their holdings for the financial year ended March 31, 2026.\n*   This is a positive signal for shareholders, indicating financial stability at the promoter level and good corporate governance.\n*   The declaration was filed with the stock exchanges (BSE, NSE, NSE IFSC) as per SEBI's Takeover Regulations.",{"company_name":558,"filing_date":570,"filing_source":9,"headline":571,"id":572,"stock_code":562,"summary_text":573},"2026-04-28T21:21:40.078000","Promoter Confirms No Pledged Shares","69f0d7aeabd16353d2ff674e","*   Promoter Mr. George Thomas Muthoot has declared that his shareholding in the company is free of any encumbrances (pledges) for the financial year ended March 31, 2026.\n*   This declaration was made in compliance with SEBI (SAST) Regulations, 2011.\n*   The absence of pledged shares is a positive governance signal for investors, mitigating risks associated with the forced selling of promoter stock.",{"company_name":575,"filing_date":576,"filing_source":9,"headline":577,"id":578,"stock_code":579,"summary_text":580},"Somany Ceramics Limited","2026-04-28T21:21:40.071000","Trading Window Closed Ahead of Q4 & FY26 Results","69f0d7b5ec7f5de862c54204","SOMANYCERA","*   A Board Meeting is scheduled for May 4, 2026, to approve the audited financial results for the quarter and year ended March 31, 2026.\n*   In compliance with SEBI regulations, the trading window for Designated Persons has been closed from April 1, 2026.\n*   The trading window will reopen 48 hours after the financial results are publicly announced.\n*   A dividend proposal may also be considered during the meeting, though it is not explicitly confirmed in the notice.",{"company_name":582,"filing_date":583,"filing_source":9,"headline":584,"id":585,"stock_code":586,"summary_text":587},"Jindal Poly Investment and Finance Company Limited","2026-04-28T21:21:40.046000","Promoters Declare Zero Pledged Shares","69f0d7b3c9cbead9b3c54478","JPOLYINVST","*   The company's promoters have filed their annual share encumbrance disclosure for the financial year ending March 31, 2026.\n*   The filing confirms that the Promoter and Promoter Group hold **zero** encumbered or pledged shares.\n*   This is a significant positive indicator for shareholders, suggesting financial stability within the promoter group and reducing a key investment risk.",{"company_name":519,"filing_date":589,"filing_source":9,"headline":590,"id":591,"stock_code":351,"summary_text":592},"2026-04-28T21:21:39.828000","Reports FY26 Loss on Impairment, Acquires Kenalog® Brand","69f0d7ca890e096a6fc5467d","*   Reports a consolidated net loss of ₹(325.94) Crores for FY26, a sharp reversal from a profit of ₹91.13 Crores in FY25.\n*   Results were impacted by a significant exceptional item: a ₹175.82 Crore impairment charge on an intangible asset under development.\n*   Standalone profit of ₹700.01 Crores was heavily supported by a non-operating forex gain of ₹381.82 Crores, masking weaker operational performance.\n*   Announced the post-year-end acquisition of the Kenalog® brand from Bristol Myers Squibb for up to USD 100 million.\n*   The Board approved the re-appointment of key leadership, including Chairperson Nandini Piramal and Executive Director Peter DeYoung.",{"company_name":326,"filing_date":594,"filing_source":9,"headline":595,"id":596,"stock_code":330,"summary_text":597},"2026-04-28T21:21:39.690000","FY26 Profits Stagnate as Bad Loans Surge; Management Signals FY27 Rebound","69f0d7ccf43b112c8d91df6f","*   \u003Cb>Profit Squeeze:\u003C\u002Fb> Full-year profit (PAT) grew only 2% to ₹10,988 Mn, severely impacted by a 143% spike in provisions for bad loans (credit costs).\n*   \u003Cb>Asset Quality Warning:\u003C\u002Fb> Gross NPA rose sharply to 3.37% from 1.79% last year, marking a significant deterioration in asset quality.\n*   \u003Cb>Slowing Growth:\u003C\u002Fb> Annual loan disbursements fell by 6% YoY, though Assets Under Management (AUM) grew by a moderate 11% to ₹1,32,246 Mn.\n*   \u003Cb>Management Outlook:\u003C\u002Fb> Despite the tough year, management guides for ~20% AUM growth in FY27, citing improved Q4 collection efficiency (98.1%) and believing \"the worst is behind us.\"",{"company_name":519,"filing_date":599,"filing_source":9,"headline":600,"id":601,"stock_code":351,"summary_text":602},"2026-04-28T21:21:39.579000","Reports FY26 Net Loss on CDMO Weakness & Impairment Charge","69f0d7dba157653c6639c9bf","*   **Financial Outcome**: The company reported a consolidated net loss of ₹326 Crores for FY26, a sharp reversal from a ₹91 Crore profit in FY25. This was primarily driven by a significant one-time impairment charge of ₹196 Crores.\n*   **Revenue Performance**: Full-year revenue declined by 3% to ₹8,869 Crores. The decline was led by its largest segment, Contract Development and Manufacturing (CDMO), which saw a 10% drop in revenue due to industry-wide destocking.\n*   **Segment Highlights**:\n    *   **Consumer Healthcare (PCH)** was the top performer, growing 17% YoY, fueled by its \"Power Brands\" and a 48% surge in e-commerce sales.\n    *   **Complex Hospital Generics (CHG)** grew 3% and completed the strategic acquisition of Kenalog® for a $35Mn upfront payment to bolster its portfolio.\n*   **Management Outlook**: Management characterized FY26 as a \"transitional year\" and projects a strong \"return to growth in FY27\" with accelerated growth in both EBITDA and PAT, citing recovery in CDMO and continued momentum in other businesses.",{"company_name":604,"filing_date":605,"filing_source":9,"headline":606,"id":607,"stock_code":608,"summary_text":609},"Lupin Limited","2026-04-28T21:21:39.555000","Promoters Declare Zero Pledged Shares for FY 2025-26","69f0d7acf35e30561cff628f","LUPIN","*   The promoter group has declared zero encumbrance (pledge) on their shares for the financial year 2025-26.\n*   This is a positive governance signal, indicating financial stability within the promoter group and reducing a key risk for shareholders.\n*   As of March 31, 2026, the promoter group holds 46.86% of the company's total equity.",true,100,1,838]